Belgium earmarks €25m for orphan drug access under rare disease plan

05-03-2026

EURACTIV - Belgium has unveiled its Rare Diseases Plan 2026–2030, backing the strategy with €4 million annually for structural reforms and €25 million to support early access to orphan medicines. Read more

Belgium's Minister of Social Affairs Frank Vandenbroucke [Photo by Tomas Tkacik/SOPA Images/LightRocket via Getty Images)]



     

    Share